San Francisco-based iRhythm Technologies secures $17 million in in Series E funding in support of its wearable Zio heart monitor.
Remote monitoring startup iRhythm touted a new $17 million Series E funding round in support of its wearable devices, saying it plans to pursue efforts in commercialization, marketing and clinical studies.
The San Francisco company offers continuous cardiac monitoring with its FDA-cleared Zio wearable device and accompanying software. The system is designed to log data on patients' heart rhythms, then process and analyze the data to kick out a report for physicians.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1qYhP2z
Cap comentari:
Publica un comentari a l'entrada